U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
150511150511Management of Diabetes in the Emergency Room: a Randomized Trial of an Insulin Protocol.CompletedHas ResultsType 2 Diabetes MellitusDrug: insulins aspart and detemirhttps://ClinicalTrials.gov/show/NCT00591227
150512150512Safety and PK Study of MP-424 to Treat Chronic Hepatitis CCompletedHas ResultsChronic Hepatitis CDrug: MP-424 (Telaprevir)https://ClinicalTrials.gov/show/NCT00591214
150513150513Efficacy, Safety, and Tolerability Study of Infliximab in Juvenile SpondyloarthropathiesCompletedNo Results AvailableSpondylarthropathiesDrug: infliximab|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00591201
150514150514Capecitabine and Interferon-Alpha in Metastatic Renal Cell Carcinoma Patients With Failure on Interleukin-2 Based RegimensCompletedNo Results AvailableCarcinoma, Renal CellDrug: capecitabine, interferon-alphahttps://ClinicalTrials.gov/show/NCT00591188
150515150515A Randomized Clinical Trial Assessing Smoking Cessation Interventions In Dental Clinic SmokersActive, not recruitingNo Results AvailableSmoking CessationBehavioral: Standard Care only|Behavioral: Dental Hygienist provided counseling + Brief Questionnaire|Behavioral: Dental Hygienist provided counseling with personalized risk communication + Brief Questionnairehttps://ClinicalTrials.gov/show/NCT00591175
150516150516Bone Disease in Severely Burned ChildrenTerminatedNo Results AvailableBurnDrug: Tetracycline|Radiation: Duel Energy X-Ray Absorptiometry (DEXA)|Procedure: Bone Biopsyhttps://ClinicalTrials.gov/show/NCT00591162
150517150517Oxaliplatin and Docetaxel Followed by Cetuximab for Head and Neck CancerTerminatedNo Results AvailableHead and Neck Cancer|Carcinoma, SquamousDrug: Oxaliplatin|Drug: Docetaxel|Drug: Cetuximabhttps://ClinicalTrials.gov/show/NCT00591149
150518150518Phase I Study of Indibulin in Patients With Solid TumorsCompletedNo Results AvailableSolid TumorsDrug: indibulinhttps://ClinicalTrials.gov/show/NCT00591136
150519150519Study of Erlotinib and Chemotherapy for Unresectable or Metastatic Cancer of the Esophagus and Gastric CardiaActive, not recruitingNo Results AvailableUnresectable Adenocarcinoma of the Esophagus|Metastatic Adenocarcinoma of the Esophagus|Unresectable Adenocarcinoma of Gastric Cardia|Metastatic Adenocarcinoma of Gastric CardiaDrug: FOLFOX and Erlotinibhttps://ClinicalTrials.gov/show/NCT00591123
150520150520Project inCharge: Increasing the Rate of Comprehensive Eye Care Utilization by Older African Americans Through Community-Based Eye Health Education ProgramCompletedNo Results AvailableEye Disease|Eye Care|VisionBehavioral: Eye care education|Behavioral: Social-contact controlhttps://ClinicalTrials.gov/show/NCT00591110
150521150521Normal Reference Ranges for Urinary Metabolites and Supersaturation Indices in Pediatric PopulationsCompletedNo Results AvailableHealthyhttps://ClinicalTrials.gov/show/NCT00591097
150522150522Ginsenoside-Rd for Acute Ischemic StrokeCompletedNo Results AvailableIschemic StrokeDrug: ginsenoside-Rd 10 mg|Drug: placebo|Drug: ginsenoside-Rd 20mghttps://ClinicalTrials.gov/show/NCT00591084
150523150523Impact of 2 Blood Glucose Levels on Hospital Mortality in Patients Admitted in ICURecruitingNo Results AvailableHyperglycemia|Critically Ill PatientsOther: Strict glycemic control|Other: Conventional glycemic controlhttps://ClinicalTrials.gov/show/NCT00591071
150524150524Safety and Dose-Finding Study of TM-601 in Adults With Recurrent Malignant GliomaActive, not recruitingNo Results AvailableMalignant Glioma|Glioblastoma Multiforme|GBM|Astrocytoma|OligodendrogliomaDrug: TM-601https://ClinicalTrials.gov/show/NCT00591058
150525150525Study of Oxaliplatin, Calcium Folinate, and 5-Fluorouracil as Neoadjuvant Chemotherapy for Resectable Advanced Gastric CancerNot yet recruitingNo Results AvailableStomach Neoplasms|Gastric CancerDrug: mFOLFOXhttps://ClinicalTrials.gov/show/NCT00591045
150526150526Approach to a Quantitative Follow-up of Non-thyroidal Illness SyndromeActive, not recruitingNo Results AvailableEuthyroid Sick Syndromes|Non-thyroidal Illness Syndrome|Low T3 Syndromehttps://ClinicalTrials.gov/show/NCT00591032
150527150527Use of Modafinil in the Treatment of TinnitusTerminatedHas ResultsTinnitusDrug: Modafinil|Other: Placebohttps://ClinicalTrials.gov/show/NCT00591019
150528150528Phenytoin as a Neuroprotective Agent Against Corticosteroid-induced Functional Imaging ChangesCompletedHas ResultsHealthyDrug: Phenytoin (brand name Dilantin)|Drug: Hydrocortisone|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00591006
150529150529Magnetic Resonance Imaging and Spectroscopy of the ProstateCompletedNo Results AvailableProstate CancerOther: MRI and MRSIhttps://ClinicalTrials.gov/show/NCT00590993
150530150530Vertebrobasilar Flow Evaluation and Risk of Transient Ischemic Attack and Stroke (VERiTAS)CompletedNo Results AvailableVertebrobasilar Insufficiency|Ischemic Attack, Transient|Cerebrovascular Disorder|Brain Ischemia|Strokehttps://ClinicalTrials.gov/show/NCT00590980
150531150531A Phase II Study of Extended Field IMRT External Beam Irradiation and Intracavitary BrachytherapyTerminatedNo Results AvailableCervical CancerRadiation: IMRT extended field external beam radiation therapy|Radiation: Brachytherapy|Drug: Cisplatinhttps://ClinicalTrials.gov/show/NCT00590967
150532150532Clinical and Molecular-Metabolic Phase II Trial of Perifosine for Recurrent/Progressive Malignant GliomasActive, not recruitingNo Results AvailableMalignant Gliomas|CNS|Brain Cancer|CancerDrug: Perifosinehttps://ClinicalTrials.gov/show/NCT00590954
150533150533Genetic Determinations for Side Effects and Response Rate for Patients Receiving Chemotherapy With Diffuse Large Cell LymphomaCompletedNo Results AvailableLymphoma|Diffuse Large CellProcedure: Blood drawhttps://ClinicalTrials.gov/show/NCT00590941
150534150534Gastric pH in Critically Ill PatientsCompletedNo Results AvailableCritically Ill Patients|Indication for Stress Ulcer ProphylaxisDrug: esomeprazole|Drug: ranitidinehttps://ClinicalTrials.gov/show/NCT00590928
150535150535Erwinase Master Treatment ProtocolNo longer availableNo Results AvailableLeukemia, Acute Lymphoblastic|Acute Lymphoid LeukemiaDrug: Erwinia L-asparaginasehttps://ClinicalTrials.gov/show/NCT00590915
150536150536Ph II OSI-774 (Erlotinib,Tarceva) In Advanced Bronchioloalveolar Cell Lung CancerCompletedNo Results AvailableBronchioloalveolar Cell Variant of Non-small Cell Lung CancerDrug: OSI-774: erlotinib, TarcevaTMhttps://ClinicalTrials.gov/show/NCT00590902
150537150537Artificial Valve Endocarditis Reduction TrialActive, not recruitingNo Results AvailableAortic Valve Disease|Mitral Valve Disease|EndocarditisDevice: Artificial Mechanical Heart Valvehttps://ClinicalTrials.gov/show/NCT00590889
150538150538The Impact of Pancreatic Islet Cell Allotransplantation on Cognitive Function in Type 1 Diabetes MellitusCompletedNo Results AvailableDiabetes Mellitus, Type 1https://ClinicalTrials.gov/show/NCT00590876
150539150539Combining Medications to Enhance Depression OutcomesCompletedHas ResultsMajor Depressive DisorderDrug: SSRI + placebo|Drug: Escitalopram + Bupropion SR|Drug: Venlafaxine XR + Mirtazapinehttps://ClinicalTrials.gov/show/NCT00590863
150540150540Non-Operative Versus Operative Treatment for High-Energy Midshaft Clavicle FracturesEnrolling by invitationNo Results AvailableHigh Energy Midshaft Clavicle FracturesDevice: ORIF with Plate and Screws|Device: Pin Fixationhttps://ClinicalTrials.gov/show/NCT00590850

* Görseller ve İçerik tekif hakkına sahip olabilir